Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $153.5000 (-0.63%) ($153.5000 - $153.5000) on Wed. Apr. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.18% (three month average) | RSI | 41 | Latest Price | $153.5000(-0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.59% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.59% (StdDev 5.18%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $155.46 | 5 Day Moving Average | $153.69(-0.12%) | 10 Day Moving Average | $151.92(1.04%) | 20 Day Moving Average | $155.46(-1.26%) | To recent high | -28.9% | To recent low | 44.5% | Market Cap | $2.467b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |